# Zoladex Plus Tamoxifen in Breast Cancer

> **NCT00827307** · NA · COMPLETED · sponsor: **Zhejiang Cancer Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Mammography
- Estrogen
- Lipemia
- Endometrium
- Ultrasonography

## Interventions

- **DRUG:** tamoxifen
- **DRUG:** Goserelin

## Key facts

- **NCT ID:** NCT00827307
- **Lead sponsor:** Zhejiang Cancer Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2011-06
- **Final completion:** 2011-08
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2011-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00827307

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00827307, "Zoladex Plus Tamoxifen in Breast Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00827307. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*